PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)
Recruiting
Phase 3
Interventional Study
Traumatic Brain Injury
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 1,100 (estimated)
- Sponsor
- Sunnybrook Health Sciences Centre · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a phase III, multi-centre, double blind, randomized controlled trial of patients with traumatic brain injury (TBI).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria
The pragmatic nature of this study seeks to include all consecutive patients presenting with significant TBI, regardless of whether ICB is evident at presentation. Inclusion criteria are the following:
i) Patients with severe TBI defined as GCS of ≤8, or
ii) Patients with moder…
Contacts